HIV Drugs Market Revenue 2025 to 2034
HIV Drugs Market Revenue 2025 to 2034
The HIV drugs market size is expected to grow from USD 36.25 billion in 2025 to USD 52.95 billion by 2034, with a CAGR of 4.3% throughout the forecast period from 2025 to 2034. The rising prevalence of HIV/AIDs, growing awareness for early diagnosis, and technological advancements drive the market.
Report ID: 10142
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 34.75 Bn
Forecast Year,
USD USD 52.95 Bn
CAGR, 2025 -
4.3%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
HIV Drugs Market Size Analysis
HIV Drugs Market Size By Drug Type 2024 to 2034 (USD )
| Drug Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nucleoside Reverse Transcriptase Inhibitors (NRTIs) | 8.69 | 9.07 | 9.47 | 9.89 | 10.33 | 10.79 | 11.26 | 11.76 | 12.28 | 12.83 | 13.39 |
| Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) | 5.21 | 5.43 | 5.66 | 5.89 | 6.14 | 6.39 | 6.66 | 6.93 | 7.22 | 7.52 | 7.84 |
| Protease Inhibitors (PIs) | 4.17 | 4.35 | 4.53 | 4.72 | 4.92 | 5.13 | 5.34 | 5.57 | 5.80 | 6.05 | 6.30 |
| Integrase Inhibitors | 6.25 | 6.53 | 6.82 | 7.12 | 7.44 | 7.76 | 8.11 | 8.46 | 8.84 | 9.23 | 9.64 |
| Entry and Fusion Inhibitors | 3.48 | 3.62 | 3.77 | 3.93 | 4.10 | 4.27 | 4.45 | 4.63 | 4.83 | 5.03 | 5.24 |
| Combination Class Drugs | 6.95 | 7.25 | 7.55 | 7.87 | 8.21 | 8.56 | 8.92 | 9.30 | 9.69 | 10.11 | 10.54 |
HIV Drugs Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 17.38 | 18.13 | 18.92 | 19.74 | 20.59 | 21.49 | 22.42 | 23.40 | 24.41 | 25.47 | 26.58 |
| Retail Pharmacies | 12.16 | 12.68 | 13.22 | 13.78 | 14.36 | 14.97 | 15.60 | 16.27 | 16.96 | 17.67 | 18.42 |
| Online Pharmacies | 5.21 | 5.44 | 5.67 | 5.91 | 6.17 | 6.43 | 6.71 | 7.00 | 7.30 | 7.61 | 7.94 |
HIV Drugs Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 13.21 | 13.79 | 14.41 | 15.05 | 15.73 | 16.43 | 17.16 | 17.93 | 18.73 | 19.56 | 20.44 |
| Europe | 9.38 | 9.77 | 10.18 | 10.60 | 11.04 | 11.50 | 11.97 | 12.47 | 12.98 | 13.52 | 14.08 |
| Asia-Pacific | 7.65 | 7.99 | 8.35 | 8.73 | 9.13 | 9.54 | 9.98 | 10.43 | 10.90 | 11.40 | 11.91 |
| Latin America | 2.43 | 2.53 | 2.62 | 2.72 | 2.83 | 2.94 | 3.05 | 3.17 | 3.29 | 3.42 | 3.55 |
| Middle East & Africa | 2.08 | 2.16 | 2.24 | 2.32 | 2.40 | 2.49 | 2.58 | 2.67 | 2.76 | 2.86 | 2.96 |
HIV Drugs Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
